The Company builds value in revenue-stage information technology and life sciences businesses. It provides growth capital as well as a range of strategic, operational and management resources to its partner companies.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
SFE stock seems to be reasonably valued. While the company appears to have a lot of overhead (they are hiring all kinds of people at executive pay-levels), it does seem to be generating some positive returns. SFE's targeted segments (healthcare and IT) and phase (early growth) seem to be right on.